atenolol has been researched along with Phobic Disorders in 13 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Phobic Disorders: Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phenelzine was widely superior to both atenolol and placebo on independent rater analyses and, to a lesser extent, on self-report, with no significant differences between atenolol and placebo." | 2.67 | Phenelzine vs atenolol in social phobia. A placebo-controlled comparison. ( Campeas, R; Davies, S; Fyer, A; Gorman, J; Gully, R; Hatterer, J; Hollander, E; Liebowitz, MR; Papp, L; Schneier, F, 1992) |
| "Phenelzine appeared to be a particularly effective treatment for the generalized form of social phobia." | 2.67 | Phenelzine and atenolol in social phobia. ( Campeas, R; Fyer, A; Gorman, J; Hatterer, J; Hollander, E; Liebowitz, MR; Papp, L; Schneier, F, 1990) |
| "Atenolol was effective in one patient." | 2.67 | Pharmacotherapy of four men with paruresis. ( Campeas, RB; Fyer, AJ; Gorman, JM; Hatterer, JA; Hollander, E; Liebowitz, MR; Papp, LA; Schneier, FR, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Turner, SM | 2 |
| Beidel, DC | 2 |
| Wolff, PL | 1 |
| Jacob, RG | 1 |
| Heimberg, RG | 1 |
| Liebowitz, MR | 8 |
| Schneier, F | 2 |
| Campeas, R | 6 |
| Hollander, E | 6 |
| Hatterer, J | 2 |
| Fyer, A | 2 |
| Gorman, J | 2 |
| Papp, L | 4 |
| Davies, S | 1 |
| Gully, R | 1 |
| Schneier, FR | 2 |
| Welkowitz, LA | 1 |
| Saoud, JB | 1 |
| Feerick, J | 1 |
| Fallon, BA | 1 |
| Street, L | 1 |
| Gitow, A | 1 |
| Ekeberg, O | 1 |
| Kjeldsen, SE | 1 |
| Eide, IK | 1 |
| Greenwood, DT | 1 |
| Enger, E | 1 |
| Hatterer, JA | 1 |
| Gorman, JM | 3 |
| Fyer, AJ | 3 |
| Campeas, RB | 1 |
| Papp, LA | 1 |
| Levin, AP | 1 |
| Sandberg, D | 2 |
| Goetz, D | 1 |
| Levin, A | 1 |
| Klein, DF | 1 |
| Fagerström, KO | 1 |
| Hugdahl, K | 1 |
| Lundström, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety[NCT00177008] | Phase 4 | 18 participants | Interventional | 2004-03-31 | Completed | ||
| Mobile-based Attentional Bias Modification Training (ABMT) for Socially Anxious Individuals[NCT06054386] | 60 participants (Anticipated) | Interventional | 2022-04-07 | Recruiting | |||
| fMRI of Emotion Regulation During RCT of CBT vs. MBSR for Social Anxiety Disorder[NCT02036658] | 108 participants (Actual) | Interventional | 2011-03-31 | Completed | |||
| Evaluation of Nonsurgical Periodontal Treatment in Patients With Social Phobia: a Randomized Controlled Clinical Trial[NCT03241277] | 45 participants (Anticipated) | Interventional | 2017-10-05 | Not yet recruiting | |||
| Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia[NCT01394471] | Phase 1 | 68 participants (Actual) | Interventional | 2011-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for atenolol and Phobic Disorders
| Article | Year |
|---|---|
Specific issues in the cognitive-behavioral treatment of social phobia.
Topics: Atenolol; Behavior Therapy; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modalit | 1993 |
9 trials available for atenolol and Phobic Disorders
| Article | Year |
|---|---|
A composite measure to determine improvement following treatment for social phobia: the Index of Social Phobia Improvement.
Topics: Adult; Atenolol; Behavior Therapy; Combined Modality Therapy; Female; Humans; Implosive Therapy; Mal | 1994 |
Social phobia: a comparison of behavior therapy and atenolol.
Topics: Adolescent; Adult; Atenolol; Behavior Therapy; Female; Humans; Male; Middle Aged; Phobic Disorders; | 1994 |
Phenelzine vs atenolol in social phobia. A placebo-controlled comparison.
Topics: Adolescent; Adult; Atenolol; Double-Blind Method; Female; Humans; Male; Middle Aged; Personality Inv | 1992 |
Effects of beta 1- and beta 2-blockade on blood pressure and sympathetic responses to flight phobia stress.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aerospace Medicine; Atenolol; Blood Pressu | 1990 |
Phenelzine and atenolol in social phobia.
Topics: Adolescent; Adult; Atenolol; Double-Blind Method; Female; Humans; Male; Phenelzine; Phobic Disorders | 1990 |
Pharmacotherapy of four men with paruresis.
Topics: Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Phenelzine; Phobic Dis | 1990 |
Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol.
Topics: Adult; Atenolol; Clinical Trials as Topic; Female; Humans; Male; Outcome and Process Assessment, Hea | 1988 |
Pharmacotherapy of social phobia. A condition distinct from panic attacks.
Topics: Adult; Atenolol; Clinical Trials as Topic; Humans; Male; Phenelzine; Phobic Disorders | 1987 |
Effect of beta-receptor blockade on anxiety with reference to the three-systems model of phobic behavior.
Topics: Adult; Anxiety; Atenolol; Blood Pressure; Diastole; Double-Blind Method; Female; Heart Rate; Humans; | 1985 |
3 other studies available for atenolol and Phobic Disorders
| Article | Year |
|---|---|
Treatment of social phobia with drugs other than benzodiazepines.
Topics: Adolescent; Atenolol; Benzamides; Buspirone; Child; Clinical Trials as Topic; Female; Fluoxetine; Hu | 1991 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Treatment of social phobia with atenolol.
Topics: Adult; Atenolol; Autonomic Nervous System; Female; Humans; Male; Middle Aged; Phobic Disorders; Soci | 1985 |